LIFE logo

ATyr Pharma (LIFE) Depreciation And Amortization

Annual D&A

$2.74 M
+$1.05 M+61.71%

December 31, 2023

Summary

Performance

1-Year Change

+61.71%

3-Year Change

+116.51%

5-Year Change

+267.43%

15-Year Change

+284.43%

LIFE Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$2.74 M
LIFE annual depreciation & amortization is currently at an all-time high

3-Year Low

$1.30 M
LIFE annual depreciation & amortization is currently +110.20% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
LIFE previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
LIFE next annual earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$55.27 M
LIFE annual total expenses is $55.27 million

Annual Operating Expenses

$55.27 M
LIFE annual total operating expenses is $55.27 million

Annual Cost Of Goods Sold

-
LIFE annual cost of goods sold value is unknown

Annual Interest Expense

-
LIFE annual interest expense value is unknown

Quarterly D&A

$770.00 K
+$363.00 K+89.19%

March 31, 2024

Summary

Performance

3-Month Change

+89.19%

1-Year Change

+1.99%

3-Year Change

+169.23%

5-Year Change

+129.17%

LIFE Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$993.00 K
LIFE quarterly depreciation & amortization is currently -22.46% below its historical high of $993.00 thousand

3-Year Low

$286.00 K
LIFE quarterly depreciation & amortization is currently +169.23% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2024
LIFE previous earnings announcement was published on Mar 31, 2024

Next Quarterly Earnings Report Date

N/A
LIFE next earnings announcement has not yet been scheduled

Related metrics

Quarterly Total Expenses

$16.87 M
LIFE quarterly total expenses is $16.87 million

Quarterly Operating Expenses

$16.87 M
LIFE quarterly total operating expenses is $16.87 million

Quarterly Cost Of Goods Sold

-
LIFE quarterly cost of goods sold value is unknown

Quarterly Interest Expense

-
LIFE quarterly interest expense value is unknown

TTM D&A

$2.76 M
+$15.00 K+0.55%

March 31, 2024

Summary

Performance

3-Month Change

+0.55%

1-Year Change

+28.07%

3-Year Change

+123.52%

5-Year Change

+101.76%

LIFE TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$3.03 M
LIFE TTM depreciation & amortization is currently -9.07% below its historical high of $3.03 million

3-Year Low

$1.23 M
LIFE TTM depreciation & amortization is currently +123.52% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2024
LIFE previous earnings announcement was published on Mar 31, 2024

Next Quarterly Earnings Report Date

N/A
LIFE next earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$55.27 M
LIFE annual total expenses is $55.27 million

Annual Operating Expenses

$55.27 M
LIFE annual total operating expenses is $55.27 million

TTM Cost Of Goods Sold

-
LIFE TTM cost of goods sold value is unknown

TTM Interest Expense

-
LIFE TTM interest expense value is unknown

LIFE Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+61.7%+2.0%+28.1%
3 y3 years+116.5%+169.2%+123.5%
5 y5 years+267.4%+129.2%+101.8%

LIFE Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high-52.4%-22.5%-62.9%-9.1%-55.3%
5 y5-yearat high-53.8%-22.5%-68.1%-9.1%-56.4%
alltimeall timeat high-74.0%-22.5%-80.3%-9.1%-92.6%

ATyr Pharma Depreciation And Amortization History

DateAnnualQuarterlyTTM
Mar 2024
-
$770.00 K(+89.2%)
$2.76 M(+0.5%)
Dec 2023
$2.74 M(+61.7%)
$407.00 K(-59.0%)
$2.74 M(-9.6%)
Sep 2023
-
$993.00 K(+69.5%)
$3.03 M(+23.6%)
Jun 2023
-
$586.00 K(-22.4%)
$2.45 M(+13.9%)
Mar 2023
-
$755.00 K(+8.3%)
$2.15 M(+27.0%)
Dec 2022
$1.70 M(+30.0%)
$697.00 K(+68.4%)
$1.70 M(+28.6%)
Sep 2022
-
$414.00 K(+44.8%)
$1.32 M(+6.9%)
Jun 2022
-
$286.00 K(-4.0%)
$1.23 M(-5.5%)
Mar 2022
-
$298.00 K(-6.9%)
$1.30 M(+0.1%)
Dec 2021
$1.30 M(+3.0%)
$320.00 K(-2.7%)
$1.30 M(+6.0%)
Sep 2021
-
$329.00 K(-8.1%)
$1.23 M(+2.4%)
Jun 2021
-
$358.00 K(+20.5%)
$1.20 M(-0.3%)
Mar 2021
-
$297.00 K(+20.7%)
$1.21 M(-4.8%)
Dec 2020
$1.27 M(-7.3%)
$246.00 K(-18.0%)
$1.27 M(-7.7%)
Sep 2020
-
$300.00 K(-17.1%)
$1.37 M(-2.9%)
Jun 2020
-
$362.00 K(+1.1%)
$1.41 M(+1.8%)
Mar 2020
-
$358.00 K(+1.7%)
$1.39 M(+1.6%)
Dec 2019
$1.37 M(+83.1%)
$352.00 K(+3.2%)
$1.37 M(+14.5%)
Sep 2019
-
$341.00 K(+1.2%)
$1.19 M(+14.4%)
Jun 2019
-
$337.00 K(+0.3%)
$1.04 M(+16.1%)
Mar 2019
-
$336.00 K(+87.7%)
$898.00 K(+20.4%)
DateAnnualQuarterlyTTM
Dec 2018
$746.00 K(+4.6%)
$179.00 K(-6.3%)
$746.00 K(+2.5%)
Sep 2018
-
$191.00 K(-0.5%)
$728.00 K(+5.7%)
Jun 2018
-
$192.00 K(+4.3%)
$689.00 K(+2.7%)
Mar 2018
-
$184.00 K(+14.3%)
$671.00 K(-5.9%)
Dec 2017
$713.00 K(-20.8%)
$161.00 K(+5.9%)
$713.00 K(-7.8%)
Sep 2017
-
$152.00 K(-12.6%)
$773.00 K(-8.3%)
Jun 2017
-
$174.00 K(-23.0%)
$843.00 K(-5.6%)
Mar 2017
-
$226.00 K(+2.3%)
$893.00 K(-0.8%)
Dec 2016
$900.00 K(+3.6%)
$221.00 K(-0.5%)
$900.00 K(-0.6%)
Sep 2016
-
$222.00 K(-0.9%)
$905.00 K(-0.2%)
Jun 2016
-
$224.00 K(-3.9%)
$907.00 K(+1.6%)
Mar 2016
-
$233.00 K(+3.1%)
$893.00 K(+2.8%)
Dec 2015
$869.00 K(+4.8%)
$226.00 K(+0.9%)
$869.00 K(+2.0%)
Sep 2015
-
$224.00 K(+6.7%)
$852.00 K(+1.8%)
Jun 2015
-
$210.00 K(+0.5%)
$837.00 K(+0.2%)
Mar 2015
-
$209.00 K(0.0%)
$835.00 K(+0.7%)
Dec 2014
$829.00 K(+16.1%)
$209.00 K(0.0%)
$829.00 K(+33.7%)
Sep 2014
-
$209.00 K(+0.5%)
$620.00 K(+50.9%)
Jun 2014
-
$208.00 K(+2.5%)
$411.00 K(+102.5%)
Mar 2014
-
$203.00 K
$203.00 K
Dec 2013
$714.00 K
-
-

FAQ

  • What is aTyr Pharma annual depreciation & amortization?
  • What is the all time high annual D&A for aTyr Pharma?
  • What is aTyr Pharma annual D&A year-on-year change?
  • What is aTyr Pharma quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for aTyr Pharma?
  • What is aTyr Pharma quarterly D&A year-on-year change?
  • What is aTyr Pharma TTM depreciation & amortization?
  • What is the all time high TTM D&A for aTyr Pharma?
  • What is aTyr Pharma TTM D&A year-on-year change?

What is aTyr Pharma annual depreciation & amortization?

The current annual D&A of LIFE is $2.74 M

What is the all time high annual D&A for aTyr Pharma?

aTyr Pharma all-time high annual depreciation & amortization is $2.74 M

What is aTyr Pharma annual D&A year-on-year change?

Over the past year, LIFE annual depreciation & amortization has changed by +$1.05 M (+61.71%)

What is aTyr Pharma quarterly depreciation & amortization?

The current quarterly D&A of LIFE is $770.00 K

What is the all time high quarterly D&A for aTyr Pharma?

aTyr Pharma all-time high quarterly depreciation & amortization is $993.00 K

What is aTyr Pharma quarterly D&A year-on-year change?

Over the past year, LIFE quarterly depreciation & amortization has changed by +$15.00 K (+1.99%)

What is aTyr Pharma TTM depreciation & amortization?

The current TTM D&A of LIFE is $2.76 M

What is the all time high TTM D&A for aTyr Pharma?

aTyr Pharma all-time high TTM depreciation & amortization is $3.03 M

What is aTyr Pharma TTM D&A year-on-year change?

Over the past year, LIFE TTM depreciation & amortization has changed by +$604.00 K (+28.07%)